Tau-Based Therapeutics for Alzheimer’s Disease: Active and Passive Immunotherapy
- 3 August 2016
- journal article
- Published by Taylor & Francis in Immunotherapy
- Vol. 8 (9) , 1119-1134
Abstract
Pharmacological manipulation of tau protein in Alzheimer’s disease included microtubule-stabilizing agents, tau protein kinase inhibitors, tau aggregation inhibitors, active and passive immunotherapies and, more recently, inhibitors of tau acetylation. Animal studies have shown that both active and passive approaches can remove tau pathology and, in some cases, improve cognitive function. Two active vaccines targeting either nonphosphorylated (AAD-vac1) and phosphorylated tau (ACI-35) have entered Phase I testing. Notwithstanding, the recent discontinuation of the monoclonal antibody RG7345 for Alzheimer’s disease, two other antitau antibodies, BMS-986168 and C2N-8E12, are also currently in Phase I testing for progressive supranuclear palsy. After the recent impressive results in animal studies obtained by salsalate, the dimer of salicylic acid, inhibitors of tau acetylation are being actively pursued.Keywords
Funding Information
- ‘Ministero della Salute,’ I.R.C.C.S. Research Program
- Programmi di Ricerca Scientifica di Rilevante Interesse Nazionale (2009E4RM4Z)
This publication has 118 references indexed in Scilit:
- Propagation of Tau Pathology in a Model of Early Alzheimer's DiseaseNeuron, 2012
- Acetylation of Tau Inhibits Its Degradation and Contributes to TauopathyNeuron, 2010
- Convergence of Amyloid-β and Tau Pathologies on Mitochondria In VivoMolecular Neurobiology, 2010
- Amyloid-β and tau synergistically impair the oxidative phosphorylation system in triple transgenic Alzheimer's disease miceProceedings of the National Academy of Sciences, 2009
- Transmission and spreading of tauopathy in transgenic mouse brainNature Cell Biology, 2009
- Mechanisms of tau-induced neurodegenerationActa Neuropathologica, 2009
- Parkinsonism and impaired axonal transport in a mouse model of frontotemporal dementiaProceedings of the National Academy of Sciences, 2008
- Multiple-motor based transport and its regulation by TauProceedings of the National Academy of Sciences, 2007
- Polymerization of hyperphosphorylated tau into filaments eliminates its inhibitory activityProceedings of the National Academy of Sciences, 2006
- Neuropathological stageing of Alzheimer-related changesActa Neuropathologica, 1991